Sacituzumab govitecan
Product Specifications
CAS Number
1491917-83-9
Target
Antibody-Drug Conjugates (ADCs) |||TROP2
Related Pathways
Immunology/Inflammation|||Antibody-drug Conjugate/ADC Related
Purity
0.984
Bioactivity
Sacituzumab govitecan (IMMU-132) is a humanized ADC compound targeting Trop-2 with anticancer activity for the study of refractory, locally advanced or metastatic breast cancer and uroepithelial cancer.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
138499-AF-ML405 100 µL
Bcl-X (Apoptosis regulator Bcl-X, B cell lymphoma 2 like, BCL XL/S, Bcl-2-like protein 1, Bcl2-L-1, BCL2L, Bcl2l1, BCLX, BclXL, BclXs, Protein phosphatase 1 regulatory subunit 52 (PPP1R52) ) (MaxLight 405) discontinued
Ask
View Details 
MBS6211842-01 0.1 mL
HCP5 (HLA Class I Histocompatibility Antigen Protein P5, HLA Complex Protein P5, Protein P5-1) (MaxLight 550)
Ask
View Details 
MBS6211842-02 5x 0.1 mL
HCP5 (HLA Class I Histocompatibility Antigen Protein P5, HLA Complex Protein P5, Protein P5-1) (MaxLight 550)
Ask
View Details